Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram and neurofeedback in depression
NCT02674529Phase 3Completed
- Sponsor
- Marta Peciña
- Start
- Sep 2016
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by Marta Peciña. Started Sep 2016; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02674529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02674529.